For example, nanoparticle-delivered ASOs targeting circRHBDD1 in gastric cancer reduced PD-L1 expression and enhanced CD8+ T cell cytotoxicity, thereby sensitizing tumors to immune checkpoint blockade (35). The gene discussed is CD8A; the disease is gastric cancer.